This year health experts say 21,000 women will be diagnosed with Ovarian Cancer. It is often called a silent killer of women, ...

Dr. Brian Drake, an OBGYN in Nacogdoches, talks about ovarian cancer. He explains what it is and some risk factors. KLTV's Jamey Boyum talks with the Gregg County Historical Museum's Jennifer White, ...

This year, the TGen Foundation’s annual Runway for Research (held in October) is slated to combine big fun and high fashion ...

Sutro Biopharma specializes in ADCs for oncology and shows promise with STRO-002 for ovarian cancer and collaborations with ...

The 108th East Texas State Fair began Friday morning. This is the first time it’s being held at a new 300-acre site off Highway 64 West in Tyler. The WELL, a group in the school dedicated to helping ...

Dr. Marty Makary, transplant surgeon and public policy researcher at Johns Hopkins University, author of Blind Spots: When ...

A Johnson & Johnson subsidiary filed bankruptcy for the third time in an ongoing effort to settle tens of thousands of ...

AbbVie ABBV announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended approving the ...

Despite being thrown off its rhythm twice already, Johnson & Johnson is making another go of its “Texas two-step” strategy to ...

New data show istisociclib (KB-0742) triggered cell death in preclinical ovarian cancer models of platinum and PARP-inhibitor (PARPi) resistance – ...

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, presented new data on Friday highlighting the impact of alterations in FBXW7, ...

Reuters noted that J&J’s third attempt at a bankruptcy settlement differs from previous efforts in part because it focuses ...